Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

1. Novo Nordisk (NYSE:NVO) has slumped over 31% this week after the company lowered its 2025 sales outlook. The company cited reduced growth expectations for Wegovy and Ozempic in the US and weaker Wegovy penetration.

2. Baxter International Inc. (NYSE:BAX) stock has lost 24.25% this week after the company reported worse-than-expected second-quarter financial results and lowered the fiscal year 2025 outlook.

3. Coinbase Global, Inc. (NASDAQ:COIN) shares fell 16.70% this week after the company reported worse-than-expected second-quarter adjusted EPS and sales.

4. ATI Inc. (NYSE:ATI) stock fell 19.77% after the company reported worse-than-expected Q2 sales results and issued third quarter adjusted EPS guidance with its midpoint below estimates.

Also Read: Berkshire Hathaway Warns of ‘Adverse Consequences on Most, If Not All, Operating Businesses’ as Q2 Results Reflect Mounting Global Pressures

5. Moderna, Inc. (NASDAQ:MRNA) shares decreased 19.38% after the company released second-quarter results.

6. Carlisle Companies Incorporated (NYSE:CSL) stock slumped 18.3% this week  after the company reported worse-than-expected second-quarter financial results.

7. Anheuser-Busch Inbev (NYSE:BUD) shares declined 15.67% after the company’s second-quarter sales missed estimates and total volumes declined.

8. United Parcel Service, Inc. (NYSE:UPS) stock decreased 18% this week after the company withheld 2025 revenue and profit forecasts amid macro uncertainty.

9. Exelixis, Inc. (NASDAQ:EXEL) stock fell 18.54% this week after the company reported worse-than-expected second-quarter revenue results.

10. Entegris, Inc. (NASDAQ:ENTG) stock decreased 18.38% this week  after the company issued third adjusted EPS guidance below estimates.

Read Next:

• Benzinga Bulls And Bears: Celestica, Carvana, Novo Nordisk — And Fed Holds Rates Despite Trump Pressure